Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer.

Rossi S, Finocchiaro G, Noia VD, Bonomi M, Cerchiaro E, Rose F, Franceschini D, Navarria P, Ceresoli GL, Beretta GD, D'Argento E, Scorsetti M, Santoro A, Toschi L.

Future Oncol. 2019 Nov;15(33):3775-3782. doi: 10.2217/fon-2019-0349. Epub 2019 Nov 11.

PMID:
31709807
2.

Exploring ayahuasca-assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada.

Argento E, Capler R, Thomas G, Lucas P, Tupper KW.

Drug Alcohol Rev. 2019 Nov;38(7):781-789. doi: 10.1111/dar.12985. Epub 2019 Sep 5.

PMID:
31489731
3.

Correlates of Suicidality Among A Community-Based Cohort of Women Sex Workers: The Protective Effect of Social Cohesion.

Argento E, Strathdee SA, Shoveller JA, Braschel M, Shannon K.

J Interpers Violence. 2019 Aug 20:886260519870167. doi: 10.1177/0886260519870167. [Epub ahead of print]

PMID:
31431099
4.

Exploring the molecular and biological background of lung neuroendocrine tumours.

Simbolo M, Di Noia V, D'Argento E, Milella M, Scarpa A, Tortora G, Bria E, Pilotto S.

J Thorac Dis. 2019 May;11(Suppl 9):S1194-S1198. doi: 10.21037/jtd.2019.03.66. No abstract available.

5.

PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysis.

Rossi A, Noia VD, Gkountakos A, D'Argento E, Sartori G, Vita E, Monteverdi S, Lombardo F, Iacovelli R, Carbognin L, Sperduti I, Milella M, Tortora G, Bria E, Pilotto S.

Immunotherapy. 2019 Jul;11(10):921-930. doi: 10.2217/imt-2018-0198. Epub 2019 Jun 3.

PMID:
31155995
6.
7.

Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really "Raising the Bar?"

Di Noia V, Vita E, Ferrara M, Strippoli A, Basso M, Schinzari G, Cassano A, Bria E, Barone C, D'Argento E.

Curr Treat Options Oncol. 2019 Feb 21;20(3):23. doi: 10.1007/s11864-019-0616-7. Review.

PMID:
30790063
8.

The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis.

Argento E, Tupper KW, Socias ME.

Int J Drug Policy. 2019 Apr;66:80-81. doi: 10.1016/j.drugpo.2018.11.006. Epub 2019 Feb 7.

PMID:
30743091
9.

Exploiting MET dysregulation in EGFR-addicted non-small-cell lung carcinoma: a further step toward personalized medicine.

Di Noia V, D'Argento E, Pilotto S, Ferrara MG, Milella M, Tortora G, Bria E.

Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S312-S317. doi: 10.21037/tlcr.2018.12.08. No abstract available.

10.

Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors.

Rossi S, Toschi L, Finocchiaro G, Di Noia V, Bonomi M, Cerchiaro E, Ceresoli GL, Beretta GD, D'Argento E, Santoro A.

Clin Lung Cancer. 2019 Mar;20(2):82-87. doi: 10.1016/j.cllc.2018.10.009. Epub 2018 Nov 2.

PMID:
30473385
11.

Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations.

Magnini D, Fuso L, Varone F, D'Argento E, Martini M, Pecoriello A, Di Noia V, Arciuolo D, Fadda G, Rindi G, Richeldi L.

Mol Diagn Ther. 2018 Dec;22(6):723-728. doi: 10.1007/s40291-018-0359-3.

PMID:
30276554
12.

The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women.

Argento E, Braschel M, Walsh Z, Socias ME, Shannon K.

J Psychopharmacol. 2018 Dec;32(12):1385-1391. doi: 10.1177/0269881118798610. Epub 2018 Sep 26.

13.

Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies.

di Noia V, D'Argento E, Pilotto S, Grizzi G, Caccese M, Iacovelli R, Tortora G, Bria E.

Expert Opin Biol Ther. 2018 Sep;18(9):937-945. doi: 10.1080/14712598.2018.1508445. Epub 2018 Aug 9. Review.

PMID:
30075697
14.

The interference between oxaliplatin & anti-EGFR therapies: a different hypothesis to explain the 'unexplainable'.

Basso M, Dadduzio V, Rossi S, D'Argento E, Strippoli A, Di Salvatore M, Orlandi A, Zurlo V, Di Noia V, Barone C.

Per Med. 2018 Jul 1;15(4):319-327. doi: 10.2217/pme-2017-0082. Epub 2018 Jun 21.

PMID:
29927360
15.

Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis.

Inno A, Di Noia V, Martini M, D'Argento E, Di Salvatore M, Arena V, Schinzari G, Orlandi A, Larocca LM, Cassano A, Barone C.

Pathol Oncol Res. 2019 Apr;25(2):513-520. doi: 10.1007/s12253-018-0404-x. Epub 2018 Mar 20.

PMID:
29557085
16.

Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?

Rossi S, Di Noia V, Tonetti L, Strippoli A, Basso M, Schinzari G, Cassano A, Leone A, Barone C, D'Argento E.

Future Oncol. 2018 Apr;14(10):919-926. doi: 10.2217/fon-2017-0499. Epub 2018 Mar 12.

PMID:
29528255
17.

Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium.

Schinzari G, Rossi E, Pierconti F, Garufi G, Monterisi S, Strippoli A, D'Argento E, Cassano A, Barone C.

Oncotarget. 2018 Jan 11;9(9):8765-8771. doi: 10.18632/oncotarget.24162. eCollection 2018 Feb 2.

18.

Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies.

Rossi S, Cassano A, Strippoli A, Schinzari G, D'Argento E, Basso M, Barone C.

Drugs Context. 2017 Nov 8;6:212506. doi: 10.7573/dic.212506. eCollection 2017.

19.

Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting.

Argento E, Strathdee SA, Tupper K, Braschel M, Wood E, Shannon K.

BMJ Open. 2017 Sep 21;7(9):e016025. doi: 10.1136/bmjopen-2017-016025.

20.

Violence, trauma and living with HIV: Longitudinal predictors of initiating crystal methamphetamine injection among sex workers.

Argento E, Strathdee SA, Goldenberg S, Braschel M, Montaner J, Shannon K.

Drug Alcohol Depend. 2017 Jun 1;175:198-204. doi: 10.1016/j.drugalcdep.2017.02.014. Epub 2017 Apr 19.

21.

DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.

Di Noia V, Basso M, Marsico V, Cerchiaro E, Rossi S, D'Argento E, Strippoli A, Schinzari G, Iezzi R, Cassano A, Barone C.

Future Oncol. 2019 Jul;15(20):2349-2360. doi: 10.2217/fon-2017-0025. Epub 2017 Apr 25.

PMID:
28440086
22.

Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?

Rossi S, Basso M, Strippoli A, Schinzari G, D'Argento E, Larocca M, Cassano A, Barone C.

Clin Colorectal Cancer. 2017 Dec;16(4):264-274. doi: 10.1016/j.clcc.2017.03.015. Epub 2017 Mar 24. Review.

PMID:
28412137
23.

Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Corallo S, D'Argento E, Strippoli A, Basso M, Monterisi S, Rossi S, Cassano A, Barone CM.

Target Oncol. 2017 Apr;12(2):153-161. doi: 10.1007/s11523-017-0479-4. Review.

PMID:
28188446
24.

State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.

Inno A, Di Noia V, D'Argento E, Modena A, Gori S.

Transl Lung Cancer Res. 2016 Dec;5(6):599-609. doi: 10.21037/tlcr.2016.11.01. Review.

25.

Erratum to: From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?

D'Argento E, Rossi S, Schinzari G, Strippoli A, Basso M, Cassano A, Barone C.

Curr Treat Options Oncol. 2016 Dec;17(12):65. No abstract available.

PMID:
27995578
26.

From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?

D'Argento E, Rossi S, Schinzari G, Strippoli A, Basso M, Cassano A, Barone C.

Curr Treat Options Oncol. 2016 Dec;17(12):59. Review. Erratum in: Curr Treat Options Oncol. 2016 Dec;17 (12 ):65.

PMID:
27766545
27.

Gastrointestinal stromal tumors (GISTs) and second malignancies: A novel "sentinel tumor"? A monoinstitutional, STROBE-compliant observational analysis.

Rodriquenz MG, Rossi S, Ricci R, Martini M, Larocca M, Dipasquale A, Quirino M, Schinzari G, Basso M, D'Argento E, Strippoli A, Barone C, Cassano A.

Medicine (Baltimore). 2016 Sep;95(38):e4718. doi: 10.1097/MD.0000000000004718.

28.

The Loss of Boystown and Transition to Online Sex Work: Strategies and Barriers to Increase Safety Among Men Sex Workers and Clients of Men.

Argento E, Taylor M, Jollimore J, Taylor C, Jennex J, Krusi A, Shannon K.

Am J Mens Health. 2018 Nov;12(6):1994-2005. doi: 10.1177/1557988316655785. Epub 2016 Jun 28.

29.

Are TKIs favourable for the elderly with non-small-cell lung cancer?

Rossi S, D'Argento E, Schinzari G, Dadduzio V, Di Noia V, Cassano A, Barone C.

Oncotarget. 2016 Jul 26;7(30):46871-46877. doi: 10.18632/oncotarget.9389.

30.

ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis.

Strippoli A, Rossi S, Martini M, Basso M, D'Argento E, Schinzari G, Barile R, Cassano A, Barone C.

Oncotarget. 2016 Jun 7;7(23):35159-68. doi: 10.18632/oncotarget.9063.

31.

Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.

Rossi S, Schinzari G, Basso M, Strippoli A, Dadduzio V, D'Argento E, Cassano A, Barone C.

Future Oncol. 2016 May;12(10):1299-307. doi: 10.2217/fon-2015-0065. Epub 2016 Mar 21. Review.

PMID:
26996100
32.

Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis.

Rossi S, D'Argento E, Basso M, Strippoli A, Dadduzio V, Cerchiaro E, Martini M, Cassano A, Barone C.

Mol Diagn Ther. 2016 Feb;20(1):55-63. doi: 10.1007/s40291-015-0176-x.

PMID:
26645830
33.

The role of dyad-level factors in shaping sexual and drug-related HIV/STI risks among sex workers with intimate partners.

Argento E, Shannon K, Nguyen P, Dobrer S, Chettiar J, Deering KN.

Drug Alcohol Depend. 2015 Dec 1;157:166-73. doi: 10.1016/j.drugalcdep.2015.10.022. Epub 2015 Oct 28.

34.

Social Cohesion Among Sex Workers and Client Condom Refusal in a Canadian Setting: Implications for Structural and Community-Led Interventions.

Argento E, Duff P, Bingham B, Chapman J, Nguyen P, Strathdee SA, Shannon K.

AIDS Behav. 2016 Jun;20(6):1275-83. doi: 10.1007/s10461-015-1230-8.

35.

Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.

Rossi S, Basso M, Strippoli A, Dadduzio V, Cerchiaro E, Barile R, D'Argento E, Cassano A, Schinzari G, Barone C.

Clin Breast Cancer. 2015 Oct;15(5):307-12. doi: 10.1016/j.clbc.2015.03.010. Epub 2015 Mar 25. Review.

PMID:
25922284
36.

Prevalence and correlates of nonmedical prescription opioid use among a cohort of sex workers in Vancouver, Canada.

Argento E, Chettiar J, Nguyen P, Montaner J, Shannon K.

Int J Drug Policy. 2015 Jan;26(1):59-66. doi: 10.1016/j.drugpo.2014.07.010. Epub 2014 Jul 31.

37.

High prevalence and partner correlates of physical and sexual violence by intimate partners among street and off-street sex workers.

Argento E, Muldoon KA, Duff P, Simo A, Deering KN, Shannon K.

PLoS One. 2014 Jul 10;9(7):e102129. doi: 10.1371/journal.pone.0102129. eCollection 2014.

38.

A systematic review of the correlates of violence against sex workers.

Deering KN, Amin A, Shoveller J, Nesbitt A, Garcia-Moreno C, Duff P, Argento E, Shannon K.

Am J Public Health. 2014 May;104(5):e42-54. doi: 10.2105/AJPH.2014.301909. Epub 2014 Mar 13. Review.

39.

Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.

Fischer B, Argento E.

Pain Physician. 2012 Jul;15(3 Suppl):ES191-203. Review.

40.

Anastrozole-related acute hepatitis with autoimmune features: a case report.

Inno A, Basso M, Vecchio FM, Marsico VA, Cerchiaro E, D'Argento E, BagalĂ  C, Barone C.

BMC Gastroenterol. 2011 Mar 31;11:32. doi: 10.1186/1471-230X-11-32.

41.

Confronting structural violence in sex work: lessons from a community-led HIV prevention project in Mysore, India.

Argento E, Reza-Paul S, Lorway R, Jain J, Bhagya M, Fathima M, Sreeram SV, Hafeezur RS, O'Neil J.

AIDS Care. 2011 Jan;23(1):69-74. doi: 10.1080/09540121.2010.498868.

PMID:
21218278
42.

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases.

Barone C, Nuzzo G, Cassano A, Basso M, Schinzari G, Giuliante F, D'Argento E, Trigila N, Astone A, Pozzo C.

Br J Cancer. 2007 Oct 22;97(8):1035-9. Epub 2007 Sep 25.

43.

Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer.

Barone C, Basso M, Schinzari G, Pozzo C, Trigila N, D'Argento E, Quirino M, Astone A, Cassano A.

Gastric Cancer. 2007;10(2):104-11. Epub 2007 Jun 25.

PMID:
17577620
44.

Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial.

Barone C, Landriscina M, Quirino M, Basso M, Pozzo C, Schinzari G, Di Leonardo G, D'Argento E, Trigila N, Cassano A.

Br J Cancer. 2007 Jan 15;96(1):21-8. Epub 2006 Dec 12.

45.

S100A13, a new marker of angiogenesis in human astrocytic gliomas.

Landriscina M, Schinzari G, Di Leonardo G, Quirino M, Cassano A, D'Argento E, Lauriola L, Scerrati M, Prudovsky I, Barone C.

J Neurooncol. 2006 Dec;80(3):251-9. Epub 2006 Jun 14.

PMID:
16773219

Supplemental Content

Loading ...
Support Center